Cheer is: More time with the family? Festive décor? Planning in advance? Today, Sam’s Club announced the results of the 2012 Study on Holiday Cheer, which set out to understand the state of holiday cheer among American consumers and discover the routines and inspirations that create cheer during a busy shopping season. The Sam’s Club study revealed that while 75 percent of consumers feel that the recent economy has an impact on their holiday cheer, 79 percent are looking forward to the 2012 holiday season.
To deliver more cheer to hopeful families this holiday, today Sam’s Club and SamsClub.com/holiday launch a host of inspirational holiday solutions for preparing the home, entertaining and gift giving. To further elevate cheer through the season, Sam’s Club has enlisted an all-star squad of Cheer Guides, national experts in decorating, entertaining and charitable giving who will inspire members with creative, fun ideas that ease the stress of the holiday season.
To view Multimedia News Release, go to http://www.multivu.com/mnr/58788-sams-club-study-reveals-true-state-of-cheer-in-america
The theological study of angels is known as . In Zoroastrianism and Abrahamic religions they are often depicted as benevolent celestial beings who act as intermediaries between Heaven and Earth, or as guardian spirits or a guiding influence.
Data presented today at the World Diabetes Congress of the International Diabetes Federation (IDF) show that adults with type 2 diabetes achieved improved glycaemic control, significantly lower rates of overall and nocturnal confirmed hypoglycaemia for the full trial period, and a significantly lower rate of severe hypoglycaemia during the maintenance period (defined as week 16 onwards) with Ryzodeg® compared to biphasic insulin aspart 30, both administered twice-daily1.
Ryzodeg® is the first combination of two distinct insulin analogues, Tresiba® (insulin degludec), the once-daily basal insulin with an ultra-long duration of action, and the well-established mealtime insulin NovoRapid® (insulin aspart), in the ratio of 70% and 30%, in one pen for people with type 2 diabetes2-4.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/64158-ryzodeg-improved-glycaemic-control
A Cigna Foundation grant to Achilles International will help determine whether running holds the key to better mental and physical development for children with autism. The Cigna Foundation today announced its $100,000 World of Difference grant to Achilles International, which has extensive anecdotal evidence showing that walking and running help people on the autism spectrum improve their emotional and physical health.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7252851-cigna-foundation-achilles-international-running-autism-study-grant/
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
Business optimism is rising, according to a recent study. Ninety-two percent of executives interviewed for The Robert Half Professional Employment Report (http://www.roberthalf.us/per) said they are confident in their firms’ growth prospects in the third quarter of 2011; 44 percent said they are very confident. This compares with 86 percent who expressed confidence in the second-quarter survey.
to view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/rhi/46963/
Corporate Executive Board (CEB) (NYSE: EXBD), a leading research and advisory services firm, today announced the release of “The Challenger Sale: Taking Control of the Customer Conversation,” a new book that confirms companies are wasting precious time and money cultivating sales people who focus on building and maintaining relationships instead of teaching business insights—the number one attribute customers value in today’s complex selling environment. “The Challenger Sale” prescribes specific steps companies can take to develop a sales force of Challengers, which in a study of more than 6,000 sales reps, consistently outperformed other types of sales reps by nearly 15 percent.
To view Multimedia News Release, go to http://www.multivu.com/mnr/52980-corporate-executive-board-new-book-the-challenger-sale-dixon-adamson
UFO Indiana to Offer New Revelations About Extra Terrestrial Life Like UFOs UFOs are becoming a reality in Indiana, We have seen and cought UFO Orb Tentacle Light Beings on film on numerous occasions. UFO Indiana is here to learn about, study and inform the public about the happenings with these tentacle orb beings.
Do you want to live a kingdom driven life? Do you want to discover your divine purpose? Do you want to discover the life you were born to live and ignite it with passion?
The kingdom driven life by Pastor Sunday Adelaja is a book that will help you to do just that. You may have been battling with questions like, what on earth am I here for?
What is the purpose of life? Matthew 6:33, Jesus instructs us to seek first the Kingdom. Seeking the kingdom of God should be our priority.
If we are going to make a significant impact on the earth, possess and disciple nations; we need to understand the precepts and principles of the kingdom.
Pastor Sunday Adelaja’s book will help you discover God’s priority for mankind, your original purpose for existence, and the source of meaning behind life.
You will be equipped with the tools, and strategies for promoting and expanding the Kingdom.
Many admit that this book is one of the top 3 books written in the last 1000 years.
To get your own copy, click here: http://this-productrocks.com/KingdomDrivenLife
Tags:
the kingdom driven life, kingdom driven life, purpose driven life, purpose of life, the purpose driven life, the purpose of life, purpose in life, what is the purpose of life, keys to the kingdom, seek first the kingdom of god, kingdom of god, evangelism, spiritual awakening, spiritual disciplines, personal growth, holy spirit, the holy spirit, spiritual gifts, word of faith, word of god, christian, christian books, spirituality, gospel, jesus, church, christianity, bible study, god, bible verses, prayer, prayers, daily devotions, discipleship, what is the kingdom of god, church leaders, spiritual leadership, church growth, kindle, kindle books, kindle book
EDAP TMS SA (Nasdaq: EDAP), the global leader in therapeutic ultrasound, announced today that new 10 year data from an international registry-based multi-center study shows 83 percent of patients had no biopsy evidence of disease after treatment with Ablatherm® HIFU, supporting the technology as a standard primary treatment for localized prostate cancer. Study results were presented at the American Urological Association (AUA) 2011 Annual Meeting, Washington, D.C.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/edap/49862/
Promotional Products Work! Week, February 25 through March 1, 2013, sponsored by Promotional Products Association International (PPAI), the world’s largest and oldest international not-for-profit promotional products association founded in 1903, is an industry event dedicated to demonstrating the importance of promotional products as a powerful and effective advertising medium. A new study released by PPAI this week, The Influence of Promotional Products on Consumer Behavior, demonstrates that advertisers and marketers, now more than ever, can look to promotional products to deliver the highest rate of reach, recall and return on investment in the advertising industry, as the most cost-effective way to impact a targeted audience in a tangible, long-lasting and memorable manner.
To view Multimedia News Release, go to http://www.multivu.com/mnr/60314-ppai-celebrates-promotional-products-work-week
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
